# Stellate Ganglion to Prevent Atrial Fibrillation

> **NCT05656170** · NA · WITHDRAWN · sponsor: **Rush University Medical Center**

## Conditions studied

- Atrial Fibrillation New Onset

## Interventions

- **PROCEDURE:** Stellate ganglion block
- **DRUG:** Bupivacain
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05656170
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-10-01
- **Primary completion:** 2024-04
- **Final completion:** 2024-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to begin study
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05656170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05656170, "Stellate Ganglion to Prevent Atrial Fibrillation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05656170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*